Rethinking Clinical Trials

JANUARY 17, 2024

The first drug that used the new process was Remdesivir in May 2020. The committee worked with communications specialists who partnered with palliative care providers and others to draft FAQs and other communication guidance for clinician teams who were having conversations about drug allocations with patients and families.

Clinical Trials 182

Clinical Trials Clinical Trials Antibody Trials 182

Rethinking Clinical Trials

OCTOBER 31, 2023

Participants should have access to investigators and the results of studies. A lot of participants have worked with their physician to stop a drug so they can participate. One of the main reasons we turn people away is because they are taking a medication that does not work with Paxlovid.

Trials 230

Trials Medicine Research Clinical Trials 230

Rethinking Clinical Trials

JULY 27, 2022

ACTIV-6 is testing medication doses approved by the FDA for other purposes, i.e., repurposed drugs. Given the history with other repurposed drugs, I was concerned people would not want to take Ivermectin. This was one of the reasons we gave people options about which drugs they were willing to take. Susanna Naggie, MD, MHS.

Trials 182

Trials Pharmacy Medicine Clinical Trials 182

Rethinking Clinical Trials

FEBRUARY 7, 2024

Winckler, RPh, Esq Chief Executive Officer Reagan-Udall Foundation for the FDA Slides Keywords U.S. Food and Drug Administration, FDA, Misinformation, Communication, Health Information Key Points U.S.             Speaker Susan C.

Regulation 162

Regulation Production Clinical Trials Clinical Trials 162

Rethinking Clinical Trials

OCTOBER 26, 2023

There is now a cure for Hepatitis C, but many people are not able to access it. point of care diagnostic tests, provide broad access to curative Hepatitis C medications with a national subscription model, with Medicare co-pay assistance and commercial insurance coverage. Rates are the highest among 20-39-year-olds.

Clinical Research 147

Clinical Research Clinical Trials Clinical Trials Research 147

Rethinking Clinical Trials

JULY 6, 2023

Over the past several years, a variety of factors have accelerated the need for decentralized trials, including the push to make trials more accessible, the increased speed of science, the possibility of environmentally conscious trials, and the need to be flexible in a rapidly changing world.

Trials 130

Trials Clinical Trials Clinical Trials Licensing 130

Bioengineer

JULY 21, 2021

In order to win the battle against COVID-19, studies to develop vaccines, drugs, devices and re-purposed drugs are urgently needed. Although drug features and study keywords were the most informative features, all four types of features are essential for accurate trial prediction.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Engineer 52